Currently, AChE inhibitors are one of the major classes of approved drugs to treat AD [38]; therefore, many research studies are still being devoted to the identification of novel agents with AChE inhibitory properties for the treatment of this neurodegenerative disease [26,27,28]. The gene discussed is ACHE; the disease is Alzheimer disease.